Recent Insider Transactions - Prime Medicine (NASDAQ: PRME)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ PRME Prime Medicine

Gottesdiener Keith Michael / director, officer: See Remarks

02/28/2025

Buy

$2.52

500,000

$1.260M

500,000

NASDAQ PRME Prime Medicine

Alenson Carman / officer: See Remarks

02/27/2025

Buy

$2.42

90,500

$219K

90,500

NASDAQ PRME Prime Medicine

Goldwasser Meredith / officer: SVP, Strategy & Corporate Ops.

02/27/2025

Buy

$2.42

90,500

$219K

90,500

NASDAQ PRME Prime Medicine

Duffield Jeremy / officer: Chief Scientific Officer

02/27/2025

Buy

$2.42

275,000

$666K

275,000

NASDAQ PRME Prime Medicine

LEE ANN L. / officer: Chief Technical Officer

02/27/2025

Buy

$2.42

275,000

$666K

275,000

NASDAQ PRME Prime Medicine

Brudnick Richard / officer: Chief Business Officer

02/27/2025

Buy

$2.42

225,000

$545K

225,000

NASDAQ PRME Prime Medicine

Reine Allan / officer: Chief Financial Officer

02/27/2025

Buy

$2.42

275,000

$666K

275,000